July 25, 2025 - 07:53

Sacramento, CA – On July 24, 2025, the California Chamber of Commerce (CalChamber) voiced its disappointment regarding newly proposed regulations surrounding automated decision-making technologies. The organization emphasizes that these regulations could impose significant burdens on businesses, potentially stifling innovation and economic growth within the state.
CalChamber argues that the rules, while aimed at ensuring transparency and fairness, may inadvertently hinder the development and deployment of advanced technologies that could benefit consumers and businesses alike. The organization believes that a more balanced approach is necessary, one that safeguards consumer rights without placing excessive restrictions on technological advancements.
The Chamber is particularly concerned about the vague language and broad scope of the regulations, which could lead to confusion and unintended consequences for businesses striving to comply. As discussions continue, CalChamber is urging policymakers to consider the potential impacts on the state's economy and the importance of fostering an environment that encourages innovation while protecting consumer interests.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...